KD Pharma Group Overview
- Year Founded
-
1988
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
IPO
- (Cancelled)
- Financing Rounds
-
5
- Investments
-
8
KD Pharma Group General Information
Description
Manufacturer of unsaturated fatty acids intended to be used as ingredients in food supplements and medicines. The company uses a patented production technology that extracts, purifies and produces Omega-3 fatty acids and other purified rich oils and related products.
Contact Information
Website
www.kdpharmagroup.comCorporate Office
- Via Campagna 30
- 6934 Bioggio
- Switzerland
Corporate Office
- Via Campagna 30
- 6934 Bioggio
- Switzerland
KD Pharma Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
KD Pharma Group Patents
KD Pharma Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4536840-A1 | Method for processing a separation product, containing carboxylic acids, of a separation process | Pending | 09-Jun-2022 | ||
| US-20260258457-A1 | Method for processing a separation product, containing carboxylic acids, of a separation process | Pending | 09-Jun-2022 | ||
| WO-2023237724-A1 | Method for processing a separation product, containing carboxylic acids, of a separation process | Inactive | 09-Jun-2022 | ||
| EP-4337951-A1 | Chromatography method and device, in particular method and device for supercritical liquid chromatography | Active | 10-May-2021 | ||
| EP-4337951-B1 | Chromatography method and device, in particular method and device for supercritical liquid chromatography | Active | 10-May-2021 | G01N30/44 |
KD Pharma Group Signals
KD Pharma Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
KD Pharma Group Investments (8)
KD Pharma Group’s most recent deal was a Buyout/LBO with DSM-Firmenich (MEG-3 Fish Oil Business). The deal was made on 25-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DSM-Firmenich (MEG-3 Fish Oil Business) | 25-Jul-2024 | Buyout/LBO | Food Products | ||
| Trigal Pharma | 04-Oct-2021 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) | 12-Apr-2021 | Buyout/LBO | Buildings and Property | ||
| Rohner (Manufacturing Assets) | 29-Mar-2021 | Buyout/LBO | Buildings and Property | ||
| KD Pharma Group (Manufacturing Site in Seal Sands, United Kingdom) | 30-May-2019 | Buyout/LBO | Buildings and Property |
KD Pharma Group Exits (1)
KD Pharma Group’s most recent exit was on 01-Jun-2017 from EyePromise. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| EyePromise | 01-Jun-2017 | Completed |
|
KD Pharma Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| OceanBlue Omega | Miami, FL |
KD Pharma Group FAQs
-
When was KD Pharma Group founded?
KD Pharma Group was founded in 1988.
-
Where is KD Pharma Group headquartered?
KD Pharma Group is headquartered in Bioggio, Switzerland.
-
What is the size of KD Pharma Group?
KD Pharma Group has 700 total employees.
-
What industry is KD Pharma Group in?
KD Pharma Group’s primary industry is BPO/Outsource Services.
-
Is KD Pharma Group a private or public company?
KD Pharma Group is a Private company.
-
What is KD Pharma Group’s current revenue?
The current revenue for KD Pharma Group is .
-
Who are KD Pharma Group’s investors?
Aberdeen Standard Investments, Pantheon Ventures (UK), and Capiton have invested in KD Pharma Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process